OPKO Health (OPK) News Today $1.48 -0.01 (-0.34%) As of 12:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Assenagon Asset Management S.A. Sells 634,254 Shares of OPKO Health, Inc. (NASDAQ:OPK)Assenagon Asset Management S.A. lessened its stake in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 42.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 856,738 shares of the biotechnology company's stock after selling 634,254 shares duringJanuary 24 at 3:16 AM | marketbeat.comBillionaire Phillip Frost's health care company settles case with federal governmentJanuary 22, 2025 | bizjournals.comOPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside PotentialJanuary 20, 2025 | insidermonkey.comOpko, BioReference to pay over $700K to resolve False Claims Act allegationsJanuary 18, 2025 | markets.businessinsider.comPhillip Md Et Al Frost Acquires 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockJanuary 18, 2025 | insidertrades.comBioReference faces $704,349 fine for medically unnecessary blood testsJanuary 18, 2025 | msn.comOpko health CEO Phillip Frost buys $220,425 in common stockJanuary 17, 2025 | msn.comPhillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost purchased 150,000 shares of the company's stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $1.47 per share, for a total transaction of $220,500.00. Following the transaction, the chief executive officer now owns 213,186,477 shares of the company's stock, valued at $313,384,121.19. This trade represents a 0.07 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.January 17, 2025 | marketbeat.comOPKO Health (NASDAQ:OPK) Lowered to Sell Rating by StockNews.comJanuary 17, 2025 | americanbankingnews.comOPKO Health, Inc. (NASDAQ:OPK) CEO Acquires $740,000.00 in StockJanuary 16, 2025 | insidertrades.comBarclays PLC Boosts Stock Position in OPKO Health, Inc. (NASDAQ:OPK)Barclays PLC grew its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 154.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 543,336 shares of the biotechnology company's stock after buying an additional 329,870 shaJanuary 16, 2025 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) CEO Buys $740,000.00 in StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost bought 500,000 shares of the stock in a transaction on Wednesday, January 15th. The shares were bought at an average cost of $1.48 per share, with a total value of $740,000.00. Following the purchase, the chief executive officer now owns 213,036,477 shares of the company's stock, valued at $315,293,985.96. This trade represents a 0.24 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.January 15, 2025 | marketbeat.comOPKO Health (NASDAQ:OPK) Downgraded to "Sell" Rating by StockNews.comStockNews.com downgraded OPKO Health from a "hold" rating to a "sell" rating in a research report on Wednesday.January 15, 2025 | marketbeat.comOPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | globenewswire.comOpko Health’s Promising Pipeline: Buy Rating Backed by Innovative Trials and Strategic CollaborationsJanuary 9, 2025 | markets.businessinsider.comOPKO Health's (OPK) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $3.00 price objective on shares of OPKO Health in a report on Wednesday.January 8, 2025 | marketbeat.comOPKO Health (NASDAQ:OPK) Upgraded by StockNews.com to "Hold" RatingStockNews.com upgraded OPKO Health from a "sell" rating to a "hold" rating in a report on Tuesday.January 7, 2025 | marketbeat.comOpko Health subsidiary announces EBV vaccine enters Phase I studyJanuary 7, 2025 | markets.businessinsider.comOPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with MerckJanuary 7, 2025 | finance.yahoo.comOPKO Health (NASDAQ:OPK) Sees Unusually-High Trading Volume - Still a Buy?OPKO Health (NASDAQ:OPK) Sees Unusually-High Trading Volume - Should You Buy?January 6, 2025 | marketbeat.comGeode Capital Management LLC Lowers Stake in OPKO Health, Inc. (NASDAQ:OPK)Geode Capital Management LLC cut its position in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 5.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,374,745 shares of the bDecember 31, 2024 | marketbeat.comHow IBD Stock Of The Day GeneDx Landed On The IBD 50 And Notched A 2,500% GainDecember 31, 2024 | msn.com3 Stocks That Wall Street Insiders Can’t Stop BuyingInsider trades are a telling indicator of C-Suite conviction but aren't always the signal for investors they could be. Only two of these stocks are good buys.December 30, 2024 | marketbeat.comShort Interest in OPKO Health, Inc. (NASDAQ:OPK) Decreases By 14.0%OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) saw a large decrease in short interest in December. As of December 15th, there was short interest totalling 84,800,000 shares, a decrease of 14.0% from the November 30th total of 98,570,000 shares. Approximately 27.4% of the company's shares are sold short. Based on an average daily volume of 3,950,000 shares, the short-interest ratio is presently 21.5 days.December 30, 2024 | marketbeat.comState Street Corp Cuts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK)State Street Corp lessened its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 8.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,715,510 shares of the biotechnology cDecember 26, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Stock Rating Lowered by StockNews.comStockNews.com lowered OPKO Health from a "hold" rating to a "sell" rating in a research note on Thursday.December 26, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Raised to Hold at StockNews.comStockNews.com upgraded shares of OPKO Health from a "sell" rating to a "hold" rating in a research report on Wednesday.December 18, 2024 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 125,000 SharesDecember 14, 2024 | insidertrades.comOPKO Health, Inc. (NASDAQ:OPK) CEO Buys $198,750.00 in StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 125,000 shares of OPKO Health stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average cost of $1.59 per share, for a total transaction of $198,750.00. Following the completion of the transaction, the chief executive officer now directly owns 212,536,477 shares in the company, valued at $337,932,998.43. This trade represents a 0.06 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.December 13, 2024 | marketbeat.comPhillip Md Et Al Frost Purchases 500,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockDecember 12, 2024 | insidertrades.comCharles Schwab Investment Management Inc. Sells 835,569 Shares of OPKO Health, Inc. (NASDAQ:OPK)Charles Schwab Investment Management Inc. trimmed its holdings in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 16.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,212,355 shares of the biotecDecember 12, 2024 | marketbeat.comIs OPKO Health (OPK) the Best NASDAQ Penny Stock to Buy Right Now?December 11, 2024 | insidermonkey.comNextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online RetailerDecember 10, 2024 | finance.yahoo.comOPKO Health (NASDAQ:OPK) investors are sitting on a loss of 59% if they invested three years agoDecember 8, 2024 | finance.yahoo.comInsider Buying: OPKO Health, Inc. (NASDAQ:OPK) CEO Buys 199,072 Shares of StockNovember 30, 2024 | insidertrades.comOPKO Health, Inc. (NASDAQ:OPK) CEO Purchases $304,580.16 in StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost purchased 199,072 shares of the firm's stock in a transaction that occurred on Friday, November 29th. The stock was bought at an average cost of $1.53 per share, with a total value of $304,580.16. Following the completion of the purchase, the chief executive officer now owns 211,911,477 shares of the company's stock, valued at $324,224,559.81. This represents a 0.09 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.November 29, 2024 | marketbeat.comRubric Capital Management LP Acquires 4,284,336 Shares of OPKO Health, Inc. (NASDAQ:OPK)Rubric Capital Management LP grew its stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 9.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,706,640 shares of the biotechnology company's stockNovember 27, 2024 | marketbeat.comPhillip Md Et Al Frost Acquires 100,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 100,000 shares of the stock in a transaction on Friday, November 22nd. The shares were bought at an average price of $1.59 per share, for a total transaction of $159,000.00. Following the purchase, the chief executive officer now owns 211,712,405 shares in the company, valued at approximately $336,622,723.95. This trade represents a 0.05 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.November 22, 2024 | marketbeat.comOPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 20, 2024 | markets.businessinsider.comNextPlat (NASDAQ: NXPL) Expands OPKO Product Promotion at Asia’s Largest Health ExpoNovember 19, 2024 | theglobeandmail.comNextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition ExpoNovember 18, 2024 | prnewswire.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 100,000 SharesNovember 15, 2024 | insidertrades.comPhillip Frost Buys Handful Of Shares In OPKO HealthNovember 11, 2024 | finance.yahoo.comBarrington Research Estimates OPKO Health FY2028 EarningsOPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities research analysts at Barrington Research increased their FY2028 earnings estimates for shares of OPKO Health in a report released on Friday, November 8th. Barrington Research analyst M. Petusky now forecasts that the biotechnology company wiNovember 11, 2024 | marketbeat.comOPKO Health Shows Strategic Progress in Q3 2024November 9, 2024 | markets.businessinsider.comOPKO Health Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 9, 2024 | finance.yahoo.comInsider Buying: OPKO Health, Inc. (NASDAQ:OPK) CEO Buys 280,183 Shares of StockNovember 9, 2024 | insidertrades.comOPKO Health: Strategic Maneuvers and Future Profitability Drive Buy RatingNovember 9, 2024 | markets.businessinsider.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 280,183 SharesOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost purchased 280,183 shares of the stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $1.50 per share, for a total transaction of $420,274.50. Following the completion of the acquisition, the chief executive officer now directly owns 211,512,405 shares of the company's stock, valued at approximately $317,268,607.50. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this link.November 8, 2024 | marketbeat.comOPKO Health's (OPK) Outperform Rating Reiterated at Barrington ResearchBarrington Research restated an "outperform" rating and set a $2.25 price target on shares of OPKO Health in a report on Friday.November 8, 2024 | marketbeat.com Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos OPK Media Mentions By Week OPK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPK News Sentiment▼0.850.58▲Average Medical News Sentiment OPK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPK Articles This Week▼34▲OPK Articles Average Week Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FOLD News Today LGND News Today GERN News Today MNKD News Today DVAX News Today CLDX News Today BCRX News Today NVAX News Today INVA News Today MYGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPK) was last updated on 1/27/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OPKO Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPK Stock Alerts